Sai Life Sciences Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 2,845

Employees

  • Stock Symbol
  • SAILIFE

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $8.86
  • (As of Monday Closing)

Sai Life Sciences General Information

Description

Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both (a) discovery/contract research (CRO) and (b) chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing.

Contact Information

Website
www.sailife.com
Formerly Known As
Sai Advantium Pharma
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • DS-7, IKP Knowledge Park
  • Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District
  • Hyderabad, Telangana 500078
  • India
+91 040
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Drug Discovery
BPO/Outsource Services
Stock Exchange
NSE
Corporate Office
  • DS-7, IKP Knowledge Park
  • Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District
  • Hyderabad, Telangana 500078
  • India
+91 040

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sai Life Sciences Stock Performance

As of 16-Jun-2025, Sai Life Sciences’s stock price is $8.86. Its current market cap is $1.85B with 209M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.86 $8.99 $7.36 - $9.47 $1.85B 209M 602K $0.10

Sai Life Sciences Financials Summary

As of 31-Mar-2025, Sai Life Sciences has a trailing 12-month revenue of $200M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023
EV 1,947,038 1,947,038
Revenue 200,413 200,413 176,984 149,064
EBITDA 52,326 52,326 37,999 22,695
Net Income 20,121 20,121 10,003 1,244
Total Assets 369,418 369,418 272,819 266,336
Total Debt 41,195 41,195 111,239 113,564
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sai Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sai Life Sciences‘s full profile, request access.

Request a free trial

Sai Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provid
Other Healthcare Services
Hyderabad, India
2,845 As of 2024

Albany, NY
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sai Life Sciences Competitors (27)

One of Sai Life Sciences’s 27 competitors is Curia, a Private Equity-Backed company based in Albany, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curia Private Equity-Backed Albany, NY
Anthem Biosciences Private Equity-Backed Bengaluru, India
Nuvisan Formerly PE-Backed Neu-Ulm, Germany
BioDuro-Sundia Private Equity-Backed Irvine, CA
Pharmaron Formerly VC-backed Beijing, China
You’re viewing 5 of 27 competitors. Get the full list »

Sai Life Sciences Patents

Sai Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-RE48622-E1 Therapeutically active pyrazolo-pyrimidine derivatives Active 20-Dec-2012

Sai Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sai Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sai Life Sciences‘s full profile, request access.

Request a free trial

Sai Life Sciences Acquisitions (2)

Sai Life Sciences’s most recent deal was a Merger/Acquisition with Prasad Drugs. The deal was made on 01-Jun-2005.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Prasad Drugs 01-Jun-2005 Merger/Acquisition Other Chemicals and Gases
Merrifield Pharma 01-Jan-2005 Merger/Acquisition Pharmaceuticals
To view Sai Life Sciences’s complete acquisitions history, request access »

Sai Life Sciences FAQs

  • When was Sai Life Sciences founded?

    Sai Life Sciences was founded in 1999.

  • Where is Sai Life Sciences headquartered?

    Sai Life Sciences is headquartered in Hyderabad, India.

  • What is the size of Sai Life Sciences?

    Sai Life Sciences has 2,845 total employees.

  • What industry is Sai Life Sciences in?

    Sai Life Sciences’s primary industry is Other Healthcare Services.

  • Is Sai Life Sciences a private or public company?

    Sai Life Sciences is a Public company.

  • What is Sai Life Sciences’s stock symbol?

    The ticker symbol for Sai Life Sciences is SAILIFE.

  • What is the current stock price of Sai Life Sciences?

    As of 16-Jun-2025 the stock price of Sai Life Sciences is $8.86.

  • What is the current market cap of Sai Life Sciences?

    The current market capitalization of Sai Life Sciences is $1.85B.

  • What is Sai Life Sciences’s current revenue?

    The trailing twelve month revenue for Sai Life Sciences is $200M.

  • Who are Sai Life Sciences’s competitors?

    Curia, Anthem Biosciences, Nuvisan, BioDuro-Sundia, and Pharmaron are some of the 27 competitors of Sai Life Sciences.

  • What is Sai Life Sciences’s annual earnings per share (EPS)?

    Sai Life Sciences’s EPS for 12 months was $0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »